1 / 8

CSC Spheroid Isolation

Supplemental Figure 1. Addition of controls and MIPE to both. A. CSC Spheroid Isolation. Dissociation of spheroids/ Clonal seeding into assay plate. 7-14 days. Spheres. 2 days. Measure Cell viability (CellTiterGlo TM ). SCM+KO+ITS. SCM+KO+ITS. B. Cell Seeding. DMEM or RPMI+5%FBS.

selah
Download Presentation

CSC Spheroid Isolation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Supplemental Figure 1 Addition of controls and MIPE to both A CSC Spheroid Isolation Dissociation of spheroids/ Clonal seeding into assay plate 7-14 days Spheres 2 days Measure Cell viability (CellTiterGloTM) SCM+KO+ITS SCM+KO+ITS B Cell Seeding DMEM or RPMI+5%FBS Adherent C D

  2. Supplemental Figure 2 ≤30% viability in both LNCaP/PANC1 ≤30% viability in Sphere ≤30% viability in both Sphere/Adherent ≤30% viability in Adherent ≤ 30% viability in PANC1 viability ≤30% in LNCaP 2 19 5 7 2 28

  3. Supplemental Figure 3 Active CRC in both LNCaP/PANC1 Active CRC CRC in Adherent Active CRC CRC in Sphere Active CRC in both Sphere/Adherent Active CRC in PANC Active CRC in LNCaP 5 5 31 16 8 24

  4. A B IC50 (mM) 12.5 IC50 (mM) 1.481 C Cell Line CRC IC50 (mM) LNCaP A -1.2 0.007 LNCaP S -1.1 0.04 PANC1 A -1.4 0.03 PANC1 S -1.4 0.01 Supplemental Figure 4

  5. Cell Line CRC IC50 (mM) LNCaP A -2.4 45.6 LNCaP S -2.1 40.7 PANC1 A -2.4 1 PANC1 S -1.4 45.6 Supplemental Figure 5

  6. Supplemental Table 1

  7. Supplemental Table 2

  8. Supplemental Table 3

More Related